Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin in Toxic Epidermal Necrolysis
NCT02037347Phase 2Terminated
- Start
- Oct 2010
- Primary completion
- Dec 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of palifermin in toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS). Started Oct 2010; status: terminated.
02
Drugs
palifermin
03
Conditions
toxic epidermal necrolysis (TEN)Stevens-Johnson syndrome (SJS)
Beyond the preview
Go deeper on NCT02037347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02037347.